Charles Allan
Chief Executive Officer
EMAIL CONNECT
charles.allan@my01.io LinkedIn
Charles Allan is passionate about using really small things to solve big problems. Being surrounded by many successful and supportive entrepreneurs, he quickly gained an ability to create teams and transform problems into solutions.
An example of his passion at work can be found during his undergraduate years at Queens University, where he helped build a microfluidic pump for an implantable therapeutic for glaucoma. This project helped ignite his entrepreneurial spirit, and, while pursuing his Masters in Bioelectrical Engineering at McGill University, he formed a team that combined engineering and technology to develop microsolutions. Some of those initial microsystems are the foundational components used by the three companies that Charles founded: MY01, Inc., Stathera, Inc., and NXTSENS Microsystems, Inc. These companies each have won several awards and been selected for important growth accelerators. They have grown to over 70 employees, and combined to raise over $50M in funding.
Ed Harvey
Chief Medical Officer
EMAIL CONNECT
Dr. Edward J. Harvey has a rich history of collaboration with basic, clinical and engineering scientists. He is a tenured Professor of Surgery at McGill University. He is the trauma research program leader at the Research Institute of the McGill University Health Centre (RI-MUHC) with over 60 investigators in his group. He is, or has been, editor-in-chief of the Canadian Journal of Surgery; editorial board member of the Journal of Orthopaedic Trauma and OTA International; chairman of the Research Committee and the Annual meeting program chair for the Orthopedic Trauma Association; chair of the Trauma Section at the Orthopaedic Research Society; and president of the Canadian Orthopaedic Association amongst other national and international positions.
Olivier Bataille
Chief Operating Officer
EMAIL CONNECT
olivier.bataille@my01.io LinkedIn
Olivier Bataille is a seasoned professional with 25 years of experience in the medical device industry. Olivier was the Vice President of Product Development and Operations at CryoCath Medtronic, Inc. Joining CryoCath in 2005 as the Vice President of Product Development with foreign expert status, Olivier led significant achievements including the release of new robust and reliable systems and devices. As a member of the executive management team, Olivier played a key role in the sale of CryoCath Technologies Inc. to Medtronic Inc. for more than 10 times revenue. Olivier holds a Baccalaureate in Mathematics and Technology, and is a mechanical engineer from Northeastern University in Boston, Massachusetts.
Andrew Morris
Chief Commercial Officer
EMAIL CONNECT
andrew.morris@my01.io LinkedIn
Andrew Morris is an accomplished commercial executive with nearly 20 years of experience in the medical industry. Before joining MY01, Andrew excelled in developing and aligning organizational strategy with commercial execution in prominent roles such as Director of Sales at Smith & Nephew and Chief Commercial Officer at Total Joint Orthopedics. With a passion for improving patients’ lives, Andrew actively gives back through volunteer work with organizations like Operation Walk Los Angeles and Team GODA. Andrew holds a Master of Business Administration (MBA) from the University of Michigan – Stephen M. Ross School of Business.
Robin Lucia
Director of Medical Education
EMAIL CONNECT
With 17 years of experience in the vascular field and a strong background in education, collaboration, and sales, Robin has an impressive track record, including selling aortic endografts, developing arterial customer device and imaging training programs, and serving as Director of Medical Education at Inari Medical. In her previous role, she designed and built sales training and customer education programs, contributing to the professional development of a significant sales force.
Dr. Edward J. Harvey has a rich history of collaboration with basic, clinical and engineering scientists. He is a tenured Professor of Surgery at McGill University. He is the trauma research program leader at the Research Institute of the McGill University Health Centre (RI-MUHC) with over 60 investigators in his group. He is, or has been, editor-in-chief of the Canadian Journal of Surgery; editorial board member of the Journal of Orthopaedic Trauma and OTA International; chairman of the Research Committee and the Annual meeting program chair for the Orthopedic Trauma Association; chair of the Trauma Section at the Orthopaedic Research Society; and president of the Canadian Orthopaedic Association amongst other national and international positions.
Charles Allan is passionate about using really small things to solve big problems. Being surrounded by many successful and supportive entrepreneurs, he quickly gained an ability to create teams and transform problems into solutions.
An example of his passion at work can be found during his undergraduate years at Queens University, where he helped build a microfluidic pump for an implantable therapeutic for glaucoma. This project helped ignite his entrepreneurial spirit, and, while pursuing his Masters in Bioelectrical Engineering at McGill University, he formed a team that combined engineering and technology to develop microsolutions. Some of those initial microsystems are the foundational components used by the three companies that Charles founded: MY01, Inc., Stathera, Inc., and NXTSENS Microsystems, Inc. These companies each have won several awards and been selected for important growth accelerators. They have grown to over 70 employees, and combined to raise over $50M in funding.
George Xereas is the Chief Technology Officer at MY01 Inc. In this role, he leads the company’s technology and product development. Prior to MY01 Inc., he served as the Chief Technology Officer for NXTSENS Microsystems Inc., a fabless MEMS based sensor company he co-founded. George obtained his PhD in Electrical and Electronics Engineering from McGill University in 2017, which was supported by the Les Vadasz Doctoral Fellowship in Engineering – Intel. George is an author in 19 high impact publications in MEMS sensors, and is an inventor in 14 utility patents.